Simplex Trading’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275 Sell
100
-4,900
-98% -$15.2K ﹤0.01% 8810
2025
Q4
$15.7K Buy
+5,000
New +$15.8K ﹤0.01% 6682
2025
Q2
Sell
-800
Closed -$1K 8490
2025
Q1
$1K Buy
+800
New +$2.02K ﹤0.01% 8129
2024
Q4
Sell
-1,000
Closed -$3K 8373
2024
Q3
$3K Hold
1,000
﹤0.01% 7801
2024
Q2
$3K Sell
1,000
-3,800
-79% -$12.6K ﹤0.01% 8062
2024
Q1
$14K Buy
4,800
+3,600
+300% +$12.9K ﹤0.01% 7354
2023
Q4
$6K Buy
+1,200
New +$3.86K ﹤0.01% 7724
2023
Q3
Sell
-600
Closed -$1K 8519
2023
Q2
$1K Buy
+600
New +$1.31K ﹤0.01% 8551
2023
Q1
Sell
-7,300
Closed -$14K 8877
2022
Q4
$14K Sell
7,300
-400
-5% -$1.03K ﹤0.01% 7193
2022
Q3
$24K Sell
7,700
-800
-9% -$2.52K ﹤0.01% 7306
2022
Q2
$30K Buy
8,500
+8,100
+2,025% +$27.7K ﹤0.01% 7135
2022
Q1
$1K Sell
400
-4,800
-92% -$20.8K ﹤0.01% 10018
2021
Q4
$25K Buy
5,200
+2,900
+126% +$16.9K ﹤0.01% 8103
2021
Q3
$18K Hold
2,300
﹤0.01% 8506
2021
Q2
$18K Buy
2,300
+2,288
+19,067% +$15.8K ﹤0.01% 8659
2021
Q1
$9K Buy
+12
New +$86 ﹤0.01% 7924

Other funds holding ACIU

Simplex Trading's ACIU Position: Q1 2026 in Review

Simplex Trading opened a new position in AC Immune (ACIU) in Q1 2026: 6,620 shares worth $18.2K. The stake represents ﹤0.01% of the portfolio and ranks #6854 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ACIU as recently as Q3 2025.

Simplex Trading first reported a position in ACIU in Q3 2020 and has held it in 14 quarters since. The position peaked at $58K in Q1 2021. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Simplex Trading held 6,620 shares of AC Immune worth $18.2K as of Q1 2026.
  • AC Immune was a new Simplex Trading position in Q1 2026.
  • AC Immune made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6854 holding.
  • Simplex Trading first reported a position in AC Immune in Q3 2020 and has held it in 14 quarters since.
  • Simplex Trading's AC Immune position peaked at $58K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.